NCT01926860View on ClinicalTrials.gov

PCV13 + Hepatitis a Vaccine for Adults

PHASE4CompletedINTERVENTIONAL
Enrollment

305

Participants

Timeline

Start Date

August 24, 2013

Primary Completion Date

October 28, 2019

Study Completion Date

April 28, 2020

Conditions
Measurement of Immune Response to Prevenar13Measurement of Immune Response to Hepatitis a
Interventions
BIOLOGICAL

Prevenar13

BIOLOGICAL

Hepatitis A vaccine

Trial Locations (2)

63188

Department of Infectious Diseases, Eskilstuna

00100

Aava Medical Centre, Helsinki

All Listed Sponsors
lead

Helsinki University Central Hospital

OTHER

NCT01926860 - PCV13 + Hepatitis a Vaccine for Adults | Biotech Hunter | Biotech Hunter